Peak Planning Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-5,166
Closed -$455K – 75
2023
Q2
$455K Sell
5,166
-411
-7% -$35.4K 0.34% 51
2023
Q1
$450K Buy
5,577
+186
+3% +$15.2K 0.36% 49
2022
Q4
$419K Buy
5,391
+2,533
+89% +$205K 0.37% 55
2022
Q3
$231K Buy
2,858
+442
+18% +$39.7K 0.21% 73
2022
Q2
$217K Buy
+2,416
New +$245K 0.18% 74
2021
Q4
$223K Sell
2,151
-101
-4% -$11.7K 0.16% 76
2021
Q3
$282K Buy
+2,252
New +$291K 0.24% 67
2021
Q1
$226K Buy
+1,914
New +$224K 0.22% 71

Other funds holding MDT

Peak Planning Group's MDT Position: Q3 2023 in Review

Peak Planning Group sold out of Medtronic (MDT) in Q3 2023, closing a stake of 5,166 shares — an estimated $455K sold.

Peak Planning Group first reported a position in MDT in Q1 2021 and held it in 8 quarters. The position peaked at $455K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Peak Planning Group reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Peak Planning Group sold 5,166 Medtronic shares in Q3 2023, an estimated $455K.
  • Peak Planning Group first reported a position in Medtronic in Q1 2021 and held it in 8 quarters.
  • Peak Planning Group's Medtronic position peaked at $455K in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Peak Planning Group's 13F filing for Q3 2023, filed 26 May 2026.